Dog Heart Medicine & Cardiac Care — Pimobendan, Diuretics & Supplements

Cardisure 10 mg is a powerful veterinary cardiac medication formulated with Pimobendan, designed for the treatment and long-term management of Congestive Heart Failure (CHF) in dogs, especially large breeds and advanced cardiac cases. This advanced formulation works through a dual-action mechanism—enhancing cardiac contractility (positive inotropic effect) while promoting vasodilation, thereby reducing preload and afterload. This significantly improves cardiac efficiency and circulation without increasing myocardial oxygen demand. Cardisure 10 mg tablets are developed using SmartTab technology, allowing double divisibility, ensuring accurate and flexible dosing based on body weight. The natural meat flavour improves acceptance, making it easier to administer even for long-term therapy. This higher strength is ideal for large breed dogs or severe CHF cases, and can also be divided to achieve cost-effective dosing strategies as prescribed by veterinarians. Key Benefits Ideal for large breed dogs and advanced CHF management Enhances heart-pumping efficiency safely Reduces cardiac workload via vasodilation Double-divisible tablets for flexible and accurate dosing Meat-flavoured for easy administration Cost-effective for long-term cardiac treatment Composition Pimobendan IP – 10 mg Mechanism of Action Positive Inotrope – Improves heart muscle contraction Vasodilator – Reduces resistance and cardiac stress Dosage & Administration Recommended dose: 0.5 mg/kg body weight per day Divide into 2 doses (0.25 mg/kg each) Use under strict veterinary supervision Available Sizes Blister pack of 10 tablets Strength: 10 mg Product Information Suitable for: Dogs (large breeds) Category: Veterinary Cardiac Medicine Form: Flavoured Tablets Brand: Dechra

Read more less

Cardisure 5 mg is a highly effective veterinary cardiac medication formulated with Pimobendan, specifically developed for the treatment and management of Congestive Heart Failure (CHF) in dogs. This advanced formulation delivers a dual-action benefit—it enhances heart muscle contraction (positive inotropic effect) while simultaneously promoting vasodilation, reducing both preload and afterload. This improves cardiac output and circulation without increasing myocardial oxygen demand, making it ideal for long-term heart care. Cardisure 5 mg tablets feature SmartTab technology, enabling double divisibility for accurate, flexible dosing based on your dog’s body weight. The natural meat flavour ensures excellent palatability, making it easier to administer even for picky dogs. This strength is commonly recommended for medium to large breed dogs or moderate to advanced CHF cases, offering a balance of potency, flexibility, and cost-effectiveness. Key Benefits Suitable for medium to large dogs with CHF Improves heart-pumping efficiency without added oxygen stress Reduces cardiac workload through vasodilation Double-divisible tablets for precise dosing flexibility Meat-flavoured for better acceptance Ideal for long-term cardiac management Composition Pimobendan IP – 5 mg Mechanism of Action Positive Inotrope – Strengthens cardiac contractions Vasodilator – Reduces preload and afterload Dosage & Administration Recommended dose: 0.5 mg/kg body weight per day Divide into 2 doses (0.25 mg/kg each) Use strictly under veterinary guidance Available Sizes Blister pack of 10 tablets Strength: 5 mg Product Information Suitable for: Dogs (medium to large breeds) Category: Veterinary Cardiac Medicine Form: Flavoured Tablets Brand: Dechra

Read more less

Cardisure 2.5 mg is a trusted veterinary cardiac medication formulated with Pimobendan, specifically designed for the treatment and long-term management of Congestive Heart Failure (CHF) in dogs. This advanced formulation provides dual therapeutic action—enhancing cardiac contractility (positive inotropic effect) while reducing cardiac workload through vasodilation. This helps improve blood circulation and overall heart efficiency without increasing oxygen demand, making it ideal for chronic cardiac care. Cardisure 2.5 mg features SmartTab technology, enabling double-divisibility for accurate, flexible dosing based on body weight. The tablets are meat-flavoured, ensuring easy administration and better compliance, especially for medium-sized dogs. This strength is commonly prescribed for medium-sized dogs or moderate CHF cases, offering an effective balance between dosing flexibility and affordability. Key Benefits Ideal for medium-sized dogs and moderate CHF management Improves heart-pumping efficiency safely Reduces cardiac workload via vasodilation Double-divisible tablets for precise dosing Palatable meat flavour for easy administration Suitable for long-term cardiac therapy Composition Pimobendan IP – 2.5 mg Mechanism of Action Positive Inotrope – Strengthens heart contractions Vasodilator – Reduces preload and afterload Dosage & Administration Recommended dose: 0.5 mg/kg body weight per day Divide into 2 doses (0.25 mg/kg each) Use under veterinary supervision Available Sizes Blister pack of 10 tablets Strength: 2.5 mg Product Information Suitable for: Dogs (medium breeds) Category: Veterinary Cardiac Medicine Form: Flavoured Tablets Brand: Dechra

Read more less

Cardisure 1.25 mg is a premium veterinary cardiac medication formulated with Pimobendan, specially designed for the management of Congestive Heart Failure (CHF) in dogs, particularly small breeds and early-stage cases requiring lower dosage. This advanced formulation works through a dual-action mechanism, improving the heart’s pumping efficiency (positive inotropy) while reducing cardiac workload via vasodilation. This ensures better circulation without increasing myocardial oxygen demand, making it a safe and effective long-term therapy. Cardisure tablets feature SmartTab double divisibility, allowing precise dose adjustments according to body weight. The natural meat flavour enhances palatability, ensuring easy administration and better compliance in dogs. The 1.25 mg strength is ideal for small dogs, puppies under supervision, and dose titration, offering flexibility and affordability in CHF management. Key Benefits Specially designed for small dogs and low-dose requirements Improves heart contractility without increasing oxygen demand Reduces preload and afterload, easing heart stress Double-divisible tablets for accurate dosing Meat-flavoured for easy acceptance Ideal for long-term CHF management Composition Pimobendan IP – 1.25 mg Mechanism of Action Positive Inotrope – Enhances cardiac muscle contraction Vasodilator – Reduces resistance and cardiac workload Dosage & Administration Recommended dose: 0.5 mg/kg body weight per day Divide into 2 doses (0.25 mg/kg each) Always follow the veterinarian's guidance Available Sizes Blister pack of 10 tablets Strength: 1.25 mg Product Information Suitable for: Dogs (especially small breeds) Category: Veterinary Cardiac Medicine Form: Flavoured Tablets Brand: Dechra

Read more less